Brief: Vir Biotechnology To Provide Business Update And Report Q2 2023 Financial Results On August 3, 2023
26/07/2023 21:59
July 26 (Reuters) - Vir Biotechnology Inc VIR.O :
* VIR BIOTECHNOLOGY TO PROVIDE BUSINESS UPDATE AND REPORT
SECOND
QUARTER 2023 FINANCIAL RESULTS ON AUGUST 3, 2023
Source text for Eikon: ID:nGNX7gwDGK
Further company coverage: VIR.O
Recent news on Vir Biotechnology
See all newsVir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Vir Biotechnology gains after up to $1.9 billion licensing deal with Gilead
Brief: Vir Biotechnology Announces Psma-Targeted Pro-Xten® Dual-Masked T-Cell Engager Vir-5500 Received FDA Fast Track Designation For The Treatment Of Prostate Cancer
Brief: Vir Biotechnology Appoints David Liu As Chief Medical Officer
Vir Biotechnology rises after naming Theravance's Sawaf as CFO